Clinical trial
Prevention of Recurrence of Herpes Simplex in Patients With Autoimmune Rheumatic Diseases
NCT07341386 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Recurrence of Herpes Simplex in Patients With Autoimmune Rheumatic Diseases
- Lead sponsor
- University of Sao Paulo General Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- June 25, 2026
- Completion date
- April 1, 2028
- Enrollment
- 62 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune rheumatic diseases, prevention, recurrent herpes simplex